Similarly, although almost every family of viruses found in mammals contains species found in humans, some virus families seem to be capable of, at best, limited spread in human populations. This conceptual model is illustrated diagrammatically in Figure 3. A schematic representation of the relationship between human viruses and viruses from other mammals. Human viruses are depicted as a subset of mammal viruses, only partially protected by a species barrier.
There are frequent minor incursions of zoonotic viruses small arrows , and many of these may not persist in human populations. Occasionally there may be a much more significant event large arrow whereby a mammal virus proves capable of einvolving adaptation to infect and transmit from humans.
Our conceptual model has practical implications for both disease surveillance and risk assessment, especially in the context of newly emerging infectious diseases. The importance of early detection of potential epidemics or pandemics cannot be over-stressed, a point made by several major studies [ 2 ].
The early detection through clinical surveillance of SARS, coupled with effective intervention based on case isolation and quarantine, prevented a potentially catastrophic pandemic [ 19 ]. It helps, of course, if we know what we are looking for and where best to look for it [ 20 ]. We currently have only the beginnings of answers to these questions. Viruses, especially respiratory viruses, are often picked out as the most obvious threat to global public health [ 2 ].
New viruses are very likely to have a zoonotic origin, almost certainly acquired from mammals or birds. All of this information is useful, but falls well short of a recipe for designing a feasible global surveillance system [ 20 ]. One strategy to increase the likelihood of early detection is to implement sentinel surveillance in people in close, high risk contact with animal populations, such as bush meat hunters or slaughterhouse workers. Pathogen discovery programmes, particularly in under-studied taxa such as wild rodents and bats [ 21 ], should also add greatly to our knowledge of potential threats to human health.
Once a novel or previously unknown virus is identified it is obviously important to assess any potential risk to public health. Initial assessments are generally based on the kinds of comparative biology approach discussed in this Chapter. A recent example of this is Schmallenberg virus, a novel virus first detected in sheep and cattle in northern Europe in Schmallenberg is an orthobunyavirus, a diverse genus of vector-borne bunyaviruses that are found in a variety of hosts but especially in ungulates.
Given these characteristics, and despite the fact that some distantly related orthobunyaviruses — notably Oropouche — do cause disease in and may even be transmitted by humans, Schmallenberg was provisionally designated low risk to humans and no human cases have yet been found [ 22 ]. The even more recently reported MERS coronavirus [ 23 ] has rightly caused much more concern. There is a continual interchange, over both epidemiological and evolutionary time scales, between viruses in humans and viruses in other animals that we cannot ignore.
RNA viruses that pose serious threats to global public health have arisen repeatedly by jumping into humans from other animals.
This has been going on for millennia and it continues today, as fast as ever and perhaps even faster. We have to anticipate that new viral threats will emerge in coming years or decades and we need to be prepared to rise to these new challenges as they appear.
It is worth pointing out that viruses were discovered in non-human animals foot-and-mouth disease virus at the very end of the 19 th century before they were identified in humans. The same is true [ 24 ] for several important kinds of viruses, such as retroviruses and lentiviruses specifically , rotaviruses, papillomaviruses and coronaviruses. A corollary of this is that veterinary rather than medical expertise may, at least initially, be our best source of knowledge about newly discovered viruses.
We have discussed the need for more effective surveillance for novel viruses but concluded that although attempts to characterise the kinds of viruses most likely to emerge are useful precise prediction is not a realistic objective, for now at least. On the other hand, there could be considerable benefit from a better understanding of RNA virus diversity in the most important host species.
At present we do not even have a complete inventory of the viruses in humans, and whilst we have some knowledge of the viruses in major livestock species we know very little about the viruses present in wild mammals or birds. These gaps can and should be filled: we need to know what is out there now, and what might be waiting around the corner.
We are grateful to past and present members of Epigroup and numerous collaborators for many fruitful discussions. National Center for Biotechnology Information , U. Microbiol Spectr. Author manuscript; available in PMC Sep Mark E. Woolhouse , 1 Kyle Adair , 1 and Liam Brierley 1. Author information Copyright and License information Disclaimer.
Email: ku. Copyright notice. The publisher's final edited version of this article is available at Microbiol Spectr. See other articles in PMC that cite the published article. Summary There are currently recognised species of RNA virus that can infect humans and, on average, 2 new species are added every year. Introduction Viruses account for only a small fraction of the or more different species of pathogen that plague humans — the great majority are bacteria, fungi or helminths [ 1 ].
The Pathogen Pyramid The categorization of viruses based simply on their ability to infect humans fails to distinguish between a vast range of epidemiologies, from occasional very mild cases of Newcastle disease virus infection to pandemics of influenza A or HIV Open in a separate window. Figure 1. Figure 2. Mechanisms As explained above, whether a virus is found at Level 2, 3 or 4 of the pyramid reflects its ability to transmit from one human to another. Virulence In public health terms the ability of a virus to spread through human populations is, of course, only part of the story: human RNA viruses also vary enormously in the degree of harm they cause, a characteristic referred to as virulence.
A Conceptual Model All of the above is consistent with the following conceptualisation of the relationship between RNA viruses which can infect humans and those found in other kinds of host, particularly other mammals.
Figure 3. Surveillance and Risk Assessment Our conceptual model has practical implications for both disease surveillance and risk assessment, especially in the context of newly emerging infectious diseases. References 1. Risk factors for human disease emergence.
Infectious diseases: preparing for the future. Human viruses: discovery and emergence. Global trends in emerging infectious diseases. Nipah virus: impact, origins and causes of emergence. Curr Inf Dis Rep. Virus Taxonomy. Elsevier; Amsterdam, The Netherlands: The diversity of human RNA viruses. Future Virology. Family level phylogenies reveal modes of macroevolution in RNA viruses. Origins of major human infectious diseases. Population biology of multi-host pathogens.
The role of evolution in the emergence of infectious diseases. Classification of viral zoonosis through receptor pattern analysis. BMC Bioinf. Host species barriers to influenza virus infections. Host phylogeny constrains cross-species emergence and establishment of rabies virus in bats.
Ecological and taxonomic variation among human RNA viruses. Journal of Clinical Virology. Ebert D, Bull J. The evolution and expression of virulence, Chapter Evolution in Health and Disease. A multicentre collaboration to investigate the cause of severe acute respiratory syndrome.
Predicting and preventing the next pandemic zoonosis. Drexler JF, et al. Bats host major mammalian paramyxoviruses. Nat Comm. Lack of evidence for Schmallenberg virus infection in highly exposed persons, Germany, Emerg Inf Dis. Cotten M, et al. Full-genome deep sequencing and phylogenetic analysis of novel human betacoronavirus.
Palmarini M. A veterinary twist on pathogen biology. Comparative aspects of infectious salmon anemia virus, an orthomyxovirus of fish, to influenza viruses. Indian J. Desselberger U. Sandvik T. Virtual screening of gene expression regulatory sites in non-coding regions of the infectious salmon anemia virus. BMC Res. Crescenzo-Chaigne B. Non coding extremities of the seven influenza virus type C vRNA segments: effect on transcription and replication by the type C and type A polymerase complexes.
Lee Y. Nucleotides in the panhandle structure of the influenza B virus virion RNA are involved in the specificity between influenza A and B viruses. Fodor E. The influenza virus panhandle is involved in the initiation of transcription. Brinson R. Structural characterization of the viral and cRNA panhandle motifs from the infectious salmon anemia virus.
Fassati A. Nuclear import of HIV-1 intracellular reverse transcription complexes is mediated by importin 7. EMBO J. Kamata M. Importin-alpha promotes passage through the nuclear pore complex of human immunodeficiency virus type 1 Vpr. Zhou H. Cell Host Microbe. Yeung M. Houzet L. Genome-wide screening using RNA interference to study host factors in viral replication and pathogenesis. Maywood ; 8 — Lever A. Insights into cellular factors that regulate HIV-1 replication in human cells.
Kincaid R. Umbach J. Influenza A virus expresses high levels of an unusual class of small viral leader RNAs in infected cells.
Shi J. Weng K. Nucleic Acids Res. Virus-encoded microRNAs: an overview and a look to the future. Omoto S. Regulation of human immunodeficiency virus 1 transcription by nef microRNA. Qureshi A. Database Oxford ; :bau Zhang Y. Klase Z. BMC Mol. Ouellet D. Schopman N. Clerc I. Barbagallo M. Potential control of human immunodeficiency virus type 1 asp expression by alternative splicing in the upstream untranslated region.
DNA Cell Biol. Kobayashi-Ishihara M. Swaminathan G. Lecellier C. A cellular microRNA mediates antiviral defense in human cells. Jopling C. Liver-specific microRNA Biogenesis and function. RNA Biol. Zhang H. Sung T. Hariharan M. Nathans R.
Sun G. Huang J. Wang X. PLoS One. Hou W. Non-coding RNAs in hepatitis C-induced hepatocellular carcinoma: dysregulation and implications for early detection, diagnosis and therapy. Leung A. Lloyd R. How do viruses interact with stress-associated RNA granules?
Banfield B. Srivastava S. Nakagawa T. Hakata Y. Romani B. Cohen E. From arrest to escape: HIV-1 Vpr cuts a deal.
Shapshak P. Casey Klockow L. The HIV-1 protein Vpr targets the endoribonuclease Dicer for proteasomal degradation to boost macrophage infection. Deng A. Okumura A. Zhou D. Yuan T. Ahn J. Laguette N. Zahoor M. HIV-1 Vpr induces interferon-stimulated genes in human monocyte-derived macrophages.
Collins D. HIV-1 accessory proteins adapt cellular adaptors to facilitate immune evasion. There are several ways people can slow the spread of a virus in lieu of drugs or vaccination.
These include thorough and frequent hand washing, eating a fruit and vegetable-rich diet, using an alcohol-based sanitizer and getting enough sleep each night. Around the world, nurses contribute to the prevention, management and containment of viral outbreaks by caring for infected patients and educating the public on prevention strategies.
Advanced practice nurses also fill a leadership role that involves working with government leaders and advocating for health care equality. Across a variety of roles and specializations, nursing professionals fight viruses in numerous ways. Some of their methods are direct, such as preventing surgical infections.
Others are legislative in nature, such as advocating for care equality by questioning imbalanced care delivery systems. Nurses also share their expertise with the public on a host of vital topics, such as care delivery models, infection prevention and the distribution of important resources.
Public health nurses were involved in managing the severe acute respiratory syndrome SARS outbreak in They did so by tracing contacts, educating the public regarding disease signs and symptoms and serving in research teams in related case control studies. Nursing researchers have also benefited HIV testing and prevention in Malawi via identifying the benefits of working with religious leaders to promote HIV testing and prevention behaviors. Additionally, nurses have developed family planning services in Kenya by providing childbearing families with the opportunity to space pregnancies to support the health of pregnant women.
Advanced practice nurses are uniquely qualified to conduct research and assist government leaders and public health officials in creating an informed response to viral outbreaks. The input and insight of experienced nurses will help prevent the spread of infectious diseases and ensure a healthier future.
Our innovative way of thinking makes us adaptable, but our focus on education makes us formidable. Skip to main content. Types of Viruses and How They Work Over many centuries and even millennia, infectious diseases such as smallpox and measles have claimed millions of lives. The Cost of Deadly Virus Infections Viruses gain their infamy through a combination of large infection rates and death, even when their power has been relatively subdued. The Three Categories of Viruses There are three different virus types that are made distinct by their shape.
0コメント